Alcohol‐associated liver disease is associated with less adverse outcomes compared to nonalcohol‐associated liver disease in patients with COVID‐19

Documenti analoghi

• Effect of varenicline on major adverse liver outcomes in alcohol‐associated liver disease: An exploratory analysis
  di: Pojsakorn Danpanichkul, et al.
  Pubblicazione: (2025)
• Effect of aging on the development and progression of alcohol‐associated liver disease
  di: Ramesh Bellamkonda, et al.
  Pubblicazione: (2025)
• Lipid droplet‐associated proteins in alcohol‐associated fatty liver disease: A proteomic approach
  di: Sathish Kumar Perumal, et al.
  Pubblicazione: (2024)
• Alarming rise in alcohol‐associated liver disease hospitalization in young adults
  di: Chun‐Wei Pan, et al.
  Pubblicazione: (2025)
• Commentary on the gut microbiome in alcohol use disorder and alcohol‐associated liver disease
  di: Cristina Llorente
  Pubblicazione: (2024)